A study analysing effectiveness of Eltrombopag in patients with Aplastic Anemia refractory patients who are refractory to immunosuppressive therapy
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Eltrombopag (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association